Lancet, J. E. et al. Final results of a phase III randomized trial of CPX-351 versus 7+3 in older patients with newly diagnosed high risk (secondary) AML. J. Clin. Oncol. 34, 7000–7000 (2016). DOI: https://doi.org/10.1200/JCO.2016.34.15_suppl.7000

Girmenia, C. et al. Posaconazole prophylaxis during front-line chemotherapy of acute myeloid leukemia: A single-center, real-life experience. Haematologica 97, 560–567 (2012). DOI: https://doi.org/10.3324/haematol.2011.053058

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3347676/

Racil, Z. et al. [Detection of 1,3-beta-D glucan for diagnosis of invasive fungal infections in hematooncological patients: usefulness for screening of invasive mycosis and for confirmation of galactomannan positive results]. Klin Mikrobiol Infekc Lek. (2009).

Lingappan, A. et al. Endogenous fungal endophthalmitis: Causative organisms, management strategies, and visual acuity outcomes. Am. J. Ophthalmol. 153, (2012). DOI: https://doi.org/10.1016/j.ajo.2011.06.020

https://pubmed.ncbi.nlm.nih.gov/21917234/

Danielescu, C., Anton, N., Stanca, H. T. & Munteanu, M. Endogenous Endophthalmitis: A Review of Case Series Published between 2011 and 2020. Journal of Ophthalmology vol. 2020 (2020). DOI: https://doi.org/10.1155/2020/8869590

https://pubmed.ncbi.nlm.nih.gov/33149945/

Shah, C. P., McKey, J., Spirn, M. J. & Maguire, J. Ocular candidiasis: A review. British Journal of Ophthalmology vol. 92 466–468 (2008). https://bjo.bmj.com/content/92/4/466 DOI: https://doi.org/10.1136/bjo.2007.133405

Karagoz, E. et al. A Comparative Study of the Effects of Intravitreal Anidulafungin, Voriconazole, and Amphotericin B in an Experimental Candida Endophthalmitis Model. Curr. Eye Res. 42, 225–232 (2017). DOI: https://doi.org/10.3109/02713683.2016.1170857

https://pubmed.ncbi.nlm.nih.gov/27348425/

Khan, F. A., Slain, D. & Khakoo, R. A. Candida endophthalmitis: Focus on current and future antifungal treatment options. Pharmacotherapy vol. 27 1711–1721 (2007). https://pubmed.ncbi.nlm.nih.gov/18041891/ DOI: https://doi.org/10.1592/phco.27.12.1711

Bienvenu, A. L. et al. Intravitreal Injections of Voriconazole for Candida Endophthalmitis: A Case Series. Ocul. Immunol. Inflamm. 28, 471–478 (2020). https://pubmed.ncbi.nlm.nih.gov/30810429 DOI: https://doi.org/10.1080/09273948.2019.1571613

Raffetin, A., Courbin, V., Jullien, V. & Dannaoui, E. In vitro combination of isavuconazole with echinocandins against azole-susceptible and -resistant Aspergillus spp. Antimicrob. Agents Chemother. 62, (2018).

https://doi.org/10.1128/AAC.01382-17. DOI: https://doi.org/10.1128/AAC.01382-17

Nagy, F. et al. In vitro and in vivo interaction of caspofungin with isavuconazole against Candida auris planktonic cells and biofilms. bioRxiv 2021.03.08.434267 (2021) doi:10.1101/2021.03.08.434267.

https://doi.org/10.1101/2021.03.08.434267 DOI: https://doi.org/10.1101/2021.03.08.434267